Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparison.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28279456)

Published in Epidemics on March 01, 2017

Authors

Amy Pinsent1, Fengchen Liu2, Michael Deiner3, Paul Emerson4, Ana Bhaktiari5, Travis C Porco6, Thomas Lietman7, Manoj Gambhir8

Author Affiliations

1: Department of Public Health and Preventative Medicine, Monash University, Melbourne, Australia. Electronic address: amy.pinsent@monash.edu.
2: F.I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.
3: F.I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
4: International Trachoma Initiative, Atlanta, GA, USA; School of Public Health, Emory University, Atlanta, GA, USA.
5: International Trachoma Initiative, Atlanta, GA, USA.
6: F.I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
7: F.I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
8: Department of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.

Articles cited by this

Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol (2008) 5.70

Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med (1999) 2.98

Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet (2011) 2.20

Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci (2005) 1.94

Trachoma. Lancet (2014) 1.57

Estimating household and community transmission of ocular Chlamydia trachomatis. PLoS Negl Trop Dis (2009) 1.52

A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis (2007) 1.48

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models. PLoS Negl Trop Dis (2015) 1.48

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection. Parasit Vectors (2015) 1.47

When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries. PLoS Negl Trop Dis (2009) 1.36

The epidemiological dynamics of infectious trachoma may facilitate elimination. Epidemics (2011) 1.23

The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis (2009) 1.12

Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions. Adv Parasitol (2015) 1.08

Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity. PLoS Negl Trop Dis (2013) 0.98

Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses. Lancet Infect Dis (2016) 0.87

Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study. BMC Med (2016) 0.82

Control of trachoma in Australia: a model based evaluation of current interventions. PLoS Negl Trop Dis (2015) 0.80

Resource planning for neglected tropical disease (NTD) control programs: feasibility study of the Tool for Integrated Planning and Costing (TIPAC). PLoS Negl Trop Dis (2014) 0.78

Improving our forecasts for trachoma elimination: What else do we need to know? PLoS Negl Trop Dis (2017) 0.78